| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |